Drug Trial Radar · NCT06876662
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Last checked: Nov 20, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
279
Planned (sponsor's estimate)
Start
May 20, 2025
Primary completion
May 2030
Study completion Dec 2032
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Mar 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study LOXO-BTK-18001/J2N-OX-JZNA. Participants in the originator study will have the opportunity to continue their assigned study intervention or continue their follow-up visits by transitioning to this study. This study will evaluate the long-term safety and efficacy of pirtobrutinib.
Conditions
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
Interventions
PirtobrutinibDrug
Administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with a Grade ≥3 treatment-emergent adverse events (TEAEs)Time frame: Time from the Date of the First Dose of Study Intervention (Study Day 1) through 30 Days (+ 7-day window) After the Date of the Last Dose of Study Intervention or The First Date Starting a New Anticancer Therapy, whichever is Earlier
Locations
36 sites in 8 countries. Site status is shown where the registry gives one.
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Florida Cancer Specialists
Sarasota, Florida · Recruiting
The Emory Clinic
Atlanta, Georgia · Recruiting
Northwestern University
Chicago, Illinois · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Mayo Clinic- Minnesota
Rochester, Minnesota · Recruiting
University Of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Cayuga Cancer Center
Ithaca, New York · Active not recruiting
Northwell Health
Lake Success, New York · Recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
New York, New York · Recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York
New York, New York · Active not recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
University of Pennsylvania Hospital
Philadelphia, Pennsylvania · Recruiting
Tennessee Oncology
Nashville, Tennessee · Recruiting
University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Swedish Cancer Institute
Seattle, Washington · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Flinders Medical Centre
Adelaide, Australia · Recruiting
Peter MacCallum Cancer Centre
Melbourne, Australia · Completed
Linear Clinical Research
Victoria, Australia · Active not recruiting
CHU de Nantes - Hotel Dieu
Nantes, France · Recruiting
IRCCS-AOU di Bologna-Policlinico S.Orsola-Malpighi
Bologna, Italy · Completed
Ospedale San Raffaele
Milan, Italy · Recruiting
Nagoya Medical Center
Aichi-Ken, Japan · Active not recruiting
National Cancer Center Hospital
Cho-ku, Japan · Completed
National Hospital Organization Kyushu Cancer Center
Fukuoka, Japan · Active not recruiting
Tokai University Hospital- Isehara Campus
Isehara, Japan · Active not recruiting
Tohoku University Hospital
Miyagi-Ken, Japan · Active not recruiting
Hokkaido University Hospital
Sapporo, Japan · Active not recruiting
Pratia MCM Krakow
Krakow, Poland · Recruiting
Instytut Hermatologii I Transfuzjologii
Warsaw, Poland · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
St James's University Hospital
Leeds, United Kingdom · Recruiting
Churchill Hospital
Oxford, United Kingdom · Recruiting
Derriford Hospital
Plymouth, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.